TABLE 1.

MiniMed 780G system use and settings post‐AHCL initiation (cohort 1)

	All users	Users ≤15 y	Users >15 y	P a
Users, n	12 870	3211	8874	‐
Sensor use, %	90.5 ± 10.2	90.5 ± 10.0	90.5 ± 10.2	.271
Time in AHCL, %	92.3 ± 13.0	92.7 ± 12.3	92.3 ± 13.0	.260
SMBG measurements per day, n	3.4 ± 1.1	3.6 ± 1.1	3.4 ± 1.0	<.0001
AHCL exits per week, n
Total	1.0 ± 1.1	1.1 ± 1.2	1.0 ± 1.0	<.0001
Initiated by the user	0.5 ± 1.0	0.6 ± 1.1	0.5 ± 0.9	.595
Initiated by the system	0.5 ± 0.6	0.6 ± 0.7	0.5 ± 0.6	<.0001
Glucose target, % of time
100 mg/dl (5.6 mmol/L)	47.7 ± 43.9	45.1 ± 43.6	48.7 ± 43.9	.0008
110 mg/dl (6.1 mmol/L)	23.2 ± 36.0	25.7 ± 37.1	22.5 ± 35.7	<.0001
120 mg/dl (6.7 mmol/L)	22.3 ± 36.7	22.2 ± 36.1	22.1 ± 36.7	.883
150 mg/dl (8.3 mmol/L)	1.9 ± 4.5	2.2 ± 4.9	1.9 ± 4.4	.002
Open loop	4.8 ± 9.2	4.8 ± 8.7	4.8 ± 9.2	.961
Active insulin time, % of time
2 h	37.6 ± 45.7	45.5 ± 47.2	35.5 ± 45	<.0001
>2 to 3 h	53.1 ± 46.5	48.7 ± 46.7	54.2 ± 46.4	<.0001
>3 to 4 h	8.9 ± 26.5	5.4 ± 20.7	10.0 ± 27.9	<.0001
>4 h	0.4 ± 5.3	0.3 ± 4.7	0.3 ± 5.1	.617

Note. All values are shown as mean ± standard deviation.

Abbreviations: AHCL, advanced hybrid closed loop; SMBG, self‐monitored blood glucose.

^a Comparison between users aged ≤15 and >15 years.